To confirm the glucose tolerance induced by TCZ treatment as a surrogate marker of insulin responsiveness, we also evaluated the insulin-induced AKT phosphorylation (pAKT) (23) in primary hepatocytes from the experimental groups shown in Figure 4D. The gene discussed is INS; the disease is glucose measurement.